Koen Andries

20.3k total citations · 4 hit papers
156 papers, 14.2k citations indexed

About

Koen Andries is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Koen Andries has authored 156 papers receiving a total of 14.2k indexed citations (citations by other indexed papers that have themselves been cited), including 105 papers in Infectious Diseases, 81 papers in Epidemiology and 41 papers in Molecular Biology. Recurrent topics in Koen Andries's work include Tuberculosis Research and Epidemiology (58 papers), HIV Research and Treatment (35 papers) and HIV/AIDS drug development and treatment (34 papers). Koen Andries is often cited by papers focused on Tuberculosis Research and Epidemiology (58 papers), HIV Research and Treatment (35 papers) and HIV/AIDS drug development and treatment (34 papers). Koen Andries collaborates with scholars based in Belgium, United States and France. Koen Andries's co-authors include Nacer Lounis, Jérôme Guillemont, Anil Koul, Rudi Pauwels, Vincent Jarlier, Éric Arnoult, Paul A. J. Janssen, Peter Verhasselt, Emma Huitric and Dirk Bald and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

Koen Andries

154 papers receiving 13.8k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis

2004 1.6k citations Koen Andries, Peter Verhasselt et al. Science profile →
The challenge of new drug discovery for tuberculosis

2011 831 citations Nacer Lounis, Jérôme Guillemont et al. profile →
Potent and selective inhibition of HIV-1 replication in vitro by a novel series of TIBO derivatives

1990 673 citations Rudi Pauwels, Koen Andries et al. profile →
Multidrug-Resistant Tuberculosis and Culture Conversion with Bedaquiline

2014 505 citations Koen Andries, Nacer Lounis et al. profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author						Papers	Cites
Koen Andries	10.1k	6.3k	5.5k	2.5k	2.0k	156	14.2k
Johan Neyts	10.1k 1.0×	6.5k 1.0×	6.6k 1.2×	2.0k 0.8×	3.7k 1.8×	688	24.7k
Masanori Baba	6.9k 0.7×	3.3k 0.5×	5.0k 0.9×	5.9k 2.3×	3.6k 1.8×	372	16.0k
Robert Snoeck	4.8k 0.5×	6.5k 1.0×	5.0k 0.9×	3.0k 1.2×	5.5k 2.7×	556	17.3k
Jan Balzarini	14.5k 1.4×	8.2k 1.3×	10.8k 2.0×	9.7k 3.8×	12.2k 6.1×	872	33.4k
Christopher M. Sassetti	7.5k 0.7×	5.6k 0.9×	7.0k 1.3×	264 0.1×	379 0.2×	119	13.2k
William R. Bishai	11.1k 1.1×	8.5k 1.3×	5.9k 1.1×	170 0.1×	836 0.4×	314	17.2k
JoAnne L. Flynn	17.0k 1.7×	12.4k 2.0×	4.3k 0.8×	631 0.2×	279 0.1×	205	23.8k
Antonio Cassone	9.1k 0.9×	6.0k 0.9×	3.1k 0.6×	241 0.1×	559 0.3×	311	14.9k
Andrea Carfı́	1.6k 0.2×	2.6k 0.4×	2.6k 0.5×	503 0.2×	286 0.1×	91	6.7k
Clifton E. Barry	19.4k 1.9×	14.5k 2.3×	11.2k 2.1×	179 0.1×	2.8k 1.4×	287	28.9k

Countries citing papers authored by Koen Andries

Since Specialization

Citations

This map shows the geographic impact of Koen Andries's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koen Andries with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koen Andries more than expected).

Fields of papers citing papers by Koen Andries

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Koen Andries. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koen Andries. The network helps show where Koen Andries may publish in the future.

Co-authorship network of co-authors of Koen Andries

This figure shows the co-authorship network connecting the top 25 collaborators of Koen Andries. A scholar is included among the top collaborators of Koen Andries based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Koen Andries. Koen Andries is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Chauffour, Aurélie, Nacer Lounis, Koen Andries, et al.. (2023). Minimal effective dose of bedaquiline administered orally and activity of a long acting formulation of bedaquiline in the murine model of leprosy. PLoS neglected tropical diseases. 17(11). e0011379–e0011379. 5 indexed citations

Coeck, Nele, Wim Mulders, Oren Tzfadia, et al.. (2023). Bedaquiline- and clofazimine- selected Mycobacterium tuberculosis mutants: further insights on resistance driven largely by Rv0678. Scientific Reports. 13(1). 10444–10444. 9 indexed citations

Kaushik, Amit, Nicole C. Ammerman, Rokeya Tasneen, et al.. (2021). Efficacy of Long-Acting Bedaquiline Regimens in a Mouse Model of Tuberculosis Preventive Therapy. American Journal of Respiratory and Critical Care Medicine. 205(5). 570–579. 9 indexed citations

Choi, Peter J., Hamish S. Sutherland, Amy S.T. Tong, et al.. (2017). Synthesis and evaluation of analogues of the tuberculosis drug bedaquiline containing heterocyclic B-ring units. Bioorganic & Medicinal Chemistry Letters. 27(23). 5190–5196. 48 indexed citations

Makarov, Vadim, Benoît Lechartier, Ming Zhang, et al.. (2014). Towards a new combination therapy for tuberculosis with next generation benzothiazinones. EMBO Molecular Medicine. 6(3). 372–383. 312 indexed citations

Franzblau, Scott G., Mary Ann DeGroote, Sang‐Hyun Cho, et al.. (2012). Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis. Tuberculosis. 92(6). 453–488. 178 indexed citations

Zhang, Tianyu, Si-Yang Li, Kathy N. Williams, Koen Andries, & Eric L. Nuermberger. (2011). Short-Course Chemotherapy with TMC207 and Rifapentine in a Murine Model of Latent Tuberculosis Infection. American Journal of Respiratory and Critical Care Medicine. 184(6). 732–737. 47 indexed citations

Olszewska, Wieslawa, Gabriela Ispas, Corinna Schnoeller, et al.. (2010). Antiviral and lung protective activity of a novel respiratory syncytial virus fusion inhibitor in a mouse model. European Respiratory Journal. 38(2). 401–408. 42 indexed citations

Truffot-Pernot, C., et al.. (2009). Sterilizing Activity of R207910 (TMC207)-containing Regimens in the Murine Model of Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 180(6). 553–557. 61 indexed citations

10.

Véziris, Nicolas, Nacer Lounis, Aurélie Chauffour, et al.. (2008). A Once-Weekly R207910-containing Regimen Exceeds Activity of the Standard Daily Regimen in Murine Tuberculosis. American Journal of Respiratory and Critical Care Medicine. 179(1). 75–79. 51 indexed citations

11.

Andries, Koen, Peter Verhasselt, Jérôme Guillemont, et al.. (2004). A Diarylquinoline Drug Active on the ATP Synthase of Mycobacterium tuberculosis. Science. 307(5707). 223–227. 1632 indexed citations breakdown →

12.

Das, Kalyan, Jianping Ding, Y. Hsiou, et al.. (1996). Crystal Structures of 8-Cl and 9-Cl TIBO Complexed with Wild-type HIV-1 RT and 8-Cl TIBO Complexed with the Tyr181Cys HIV-1 RT Drug-resistant Mutant. Journal of Molecular Biology. 264(5). 1085–1100. 159 indexed citations

13.

Staszewski, Schlomo, Veronica Miller, Robert Colebunders, et al.. (1996). Evaluation of the efficacy and tolerance of R 018893, R 089439 (loviride) and placebo in asymptomatic HIV-1-infected patients. Antiviral Therapy. 1(1). 43–51. 5 indexed citations

14.

Vandamme, Anne–Mieke, Zeger Debyser, Rudi Pauwels, et al.. (1994). Characterization of HIV-1 Strains Isolated from Patients Treated with TIBO R82913. AIDS Research and Human Retroviruses. 10(1). 39–46. 36 indexed citations

15.

Andries, Koen & J. V. Smith. (1994). Opening, stellation and handle replacement of edges of the cube, tetrahedron and hexagonal prism: application to 3-connected three-dimensional polyhedra and (2, 3)-connected polyhedral units in three-dimensional nets. Proceedings of the Royal Society of London Series A Mathematical and Physical Sciences. 444(1920). 217–238. 8 indexed citations

16.

Geißler, R. G., Arnold Ganser, Oliver G. Ottmann, et al.. (1991). TIBO R82913, A New HIV-1 Inhibiting Agent, Does Not Inhibit Hematopoietic Progenitor Cells. AIDS Research and Human Retroviruses. 7(12). 1021–1023. 1 indexed citations

17.

Andries, Koen, B. Dewindt, Jos Snoeks, et al.. (1991). A comparative test of fifteen compounds against all known human rhinovirus serotypes as a basis for a more rational screening program. Antiviral Research. 16(3). 213–225. 45 indexed citations

18.

Andries, Koen, B. Dewindt, Jos Snoeks, & Rudy Willebrords. (1989). Lack of quantitative correlation between inhibition of replication of rhinoviruses by an antiviral drug and their stabilization. Archives of Virology. 106(1-2). 51–61. 27 indexed citations

19.

Andries, Koen, et al.. (1980). Virus Isolation and Immunofluorescence in Different Organs of Pigs Infected with Hemagglutinating Encephalomyelitis Virus. American Journal of Veterinary Research. 41(2). 215–218. 6 indexed citations

20.

Andries, Koen, et al.. (1978). Effect of Experimental Infection with Pseudorabies (Aujeszky's Disease) Virus on Pigs with Maternal Immunity from Vaccinated Sows. American Journal of Veterinary Research. 39(8). 1282–1285. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact